In principle, the data indicate that neither CD133 nor CD44 are per se CSC markers as their expression seems highly plastic in CRC cells, and their usefulness as surrogate markers for engraftment capacity appears to be environmentally conditioned. This evidence concerns the gene PROM1 and colorectal carcinoma.